Skip to main content

Alzheimer's Disease

By Anthony Vecchione | 02:56 pm | January 28, 2025
Neurotechnology company, Grey Matter Neurosciences, announced it secured $14 million in seed financing, which will be used to develop an ultrasound headset for individuals with Alzheimer's disease and test that device in clinical trials.
By Adam Ang | 07:46 am | January 10, 2025
The analytical tool can also predict demographics and understand personality traits by understanding brain activity patterns.

MobiHealthNews

September 18-19, 2025 | Chicago, IL

AI Leadership Strategy Summit

AI is transforming healthcare — but for executive leaders, adoption isn’t the only challenge. You need to make smart investments, implement proper governance, and deliver real results